Pacer Advisors Inc. Grows Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Pacer Advisors Inc. increased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 17.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 4,569 shares of the medical instruments supplier’s stock after purchasing an additional 687 shares during the quarter. Pacer Advisors Inc.’s holdings in Mettler-Toledo International were worth $5,591,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. International Assets Investment Management LLC boosted its stake in shares of Mettler-Toledo International by 149,870.0% during the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after purchasing an additional 89,922 shares during the period. Seilern Investment Management Ltd purchased a new stake in Mettler-Toledo International during the 4th quarter valued at $89,221,000. Canoe Financial LP grew its holdings in Mettler-Toledo International by 576.5% in the 4th quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock worth $67,936,000 after acquiring an additional 47,311 shares during the last quarter. Retirement Systems of Alabama grew its holdings in Mettler-Toledo International by 610.4% in the 3rd quarter. Retirement Systems of Alabama now owns 33,462 shares of the medical instruments supplier’s stock worth $50,183,000 after acquiring an additional 28,752 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after acquiring an additional 28,478 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Trading Down 1.1 %

NYSE MTD opened at $1,338.58 on Thursday. The stock has a market cap of $28.24 billion, a P/E ratio of 36.09, a P/E/G ratio of 4.19 and a beta of 1.12. Mettler-Toledo International Inc. has a 12 month low of $1,133.46 and a 12 month high of $1,546.93. The stock’s fifty day moving average price is $1,257.26 and its 200-day moving average price is $1,343.51.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. As a group, analysts forecast that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price target for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Wells Fargo & Company reduced their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Stifel Nicolaus lowered their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $1,351.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.